# A Study of Single Dose of LP-003 in Healthy Adult Subjects

> **NCT06604949** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Longbio Pharma** · enrollment: 12 (actual)

## Conditions studied

- Chronic Spontaneous Urticaria

## Interventions

- **DRUG:** LP-003 200mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06604949
- **Lead sponsor:** Longbio Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-10-23
- **Primary completion:** 2026-11
- **Final completion:** 2026-12
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06604949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06604949, "A Study of Single Dose of LP-003 in Healthy Adult Subjects". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06604949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*